Clinical Trial: Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07466030) titled 'Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate' on March 04.

Brief Summary: The aim of this study is to evaluate the impact of daily tadalafil 5 mg on storage lower urinary tract symptoms (LUTS) during the early postoperative period following Anatomical endoscopic enucleation of prostate in a randomized controlled clinical trial.

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: BPH (Benign Prostatic Hyperplasia)

Intervention: DRUG: Tadalafil 5mg (Male)

Tadalafil 5 mg is a phosphodiesterase type 5 (PDE-5) inhibitor taken orally, commonly prescribe...